These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36821541)

  • 1. The Cryptococcus wall: A different wall for a unique lifestyle.
    Mukaremera L
    PLoS Pathog; 2023 Feb; 19(2):e1011141. PubMed ID: 36821541
    [No Abstract]   [Full Text] [Related]  

  • 2. [Formation of mucoid capsules in vitro by Cryptococcus neoformans].
    Listemann H
    Mykosen; 1986 Dec; 29(12):556-8. PubMed ID: 3547122
    [No Abstract]   [Full Text] [Related]  

  • 3. Targeting the Cryptococcus neoformans var. grubii cell wall using lectins: study of the carbohydrate-binding domain.
    de Brito Ximenes P; Beltrão EI; Macêdo DP; Buonafina MD; de Lima-Neto RG; Neves RP
    Molecules; 2015 Feb; 20(3):3776-82. PubMed ID: 25723851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The morphology of Cryptococcus neoformans in human cryptococcosis. A light-,phase-contrast and electron-microscopic study.
    Stoetzner H; Kemmer C
    Mycopathol Mycol Appl; 1971 Dec; 45(3):327-35. PubMed ID: 4134556
    [No Abstract]   [Full Text] [Related]  

  • 5. Capsule deficient cryptococcus neoformans an unusual clinical presentation.
    Attal HC; Grover S; Bansal MP; Chaubey BS; Joglekar VK
    J Assoc Physicians India; 1983 Jan; 31(1):49-51. PubMed ID: 6352665
    [No Abstract]   [Full Text] [Related]  

  • 6. Cryptococcus neoformans of unusual morphology.
    Cruickshank JG; Cavill R; Jelbert M
    Appl Microbiol; 1973 Feb; 25(2):309-12. PubMed ID: 4121033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cryptococcus neoformans, var. neoformans, Cryptococcus neoformans var. gattii, causative agents of cryptococcosis].
    Swinne D; Lumbila M
    Bull Mem Acad R Med Belg; 1987; 142(2-3):238-48. PubMed ID: 3311260
    [No Abstract]   [Full Text] [Related]  

  • 8. New, special stain for histopathological diagnosis of cryptococcosis.
    Kwon-Chung KJ; Hill WB; Bennett JE
    J Clin Microbiol; 1981 Feb; 13(2):383-7. PubMed ID: 6162857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanin deposition in two
    Chrissian C; Camacho E; Fu MS; Prados-Rosales R; Chatterjee S; Cordero RJB; Lodge JK; Casadevall A; Stark RE
    J Biol Chem; 2020 Feb; 295(7):1815-1828. PubMed ID: 31896575
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of different media on the synthesis of capsular material in Cryptococcus neoformans.
    Abou-Gabal M; Atia M
    Mykosen; 1979 Aug; 22(8):289-92. PubMed ID: 398448
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification and characterization of Cryptococcus neoformans protein fractions that induce protective immune responses.
    Chaturvedi AK; Weintraub ST; Lopez-Ribot JL; Wormley FL
    Proteomics; 2013 Dec; 13(23-24):3429-41. PubMed ID: 24170628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infections with organisms deficient in capsules and cell walls.
    Deshpande DV
    J Assoc Physicians India; 1983 Jan; 31(1):5. PubMed ID: 6352666
    [No Abstract]   [Full Text] [Related]  

  • 13. PERCUTANEOUS CRYPTOCOCCUS NEOFORMANS INOCULATION WITHOUT INFECTION.
    HALDE C
    Arch Dermatol; 1964 Apr; 89():545. PubMed ID: 14107618
    [No Abstract]   [Full Text] [Related]  

  • 14. Cryptococcus neoformans.
    LUNEY MI
    Can J Med Technol; 1961 Sep; 23():121-6. PubMed ID: 14467414
    [No Abstract]   [Full Text] [Related]  

  • 15. High Prevalence of HIV-Related Cryptococcosis and Increased Resistance to Fluconazole of the
    Yang C; Bian Z; Blechert O; Deng F; Chen H; Li Y; Yang Y; Chen M; Zhan P
    Front Cell Infect Microbiol; 2021; 11():723251. PubMed ID: 34790585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell wall chitosan is necessary for virulence in the opportunistic pathogen Cryptococcus neoformans.
    Baker LG; Specht CA; Lodge JK
    Eukaryot Cell; 2011 Sep; 10(9):1264-8. PubMed ID: 21784998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Torula meningo-encephalitis (Cryptococcus neoformans)].
    SPOTA BB; MONSERRAT JL; BARDECI CA
    Rev Asoc Med Argent; 1951 Mar; 65(697):53-7. PubMed ID: 14854413
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection.
    Diamond RD; May JE; Kane MA; Frank MM; Bennett JE
    J Immunol; 1974 Jun; 112(6):2260-70. PubMed ID: 4596700
    [No Abstract]   [Full Text] [Related]  

  • 19. Taxonomy of Cryptococcus neoformans and its variety uniguttulatus.
    KREGER-VAN RIJ NJ
    Antonie Van Leeuwenhoek; 1961; 27():59-64. PubMed ID: 13754194
    [No Abstract]   [Full Text] [Related]  

  • 20. PRODUCTION OF DELAYED HYPERSENSITIVITY TO CRYPTOCOCCUS NEOFORMANS IN EXPERIMENTAL ANIMALS.
    LOMANITZ R; HALE JM
    J Bacteriol; 1963 Sep; 86(3):505-9. PubMed ID: 14066429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.